Please assess the completion status of the following clinical trial:

Trial Title: Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with type 2 diabetes per WHO criteria.~* Swiss ethnicity (defined as self-reported ancestry and parents and at least 1 grandparents are from Switzerland)~* Tamil ethnicity (defined as self-reported ancestry and parents and at least 1 grandparents are from Sri Lanka, belonging to ethnic identity of Tamils, respectively)~* Age limit: 18 - 75 years~Exclusion Criteria:~* Subjects with type 1 diabetes, steroid-induced diabetes, gestation diabetes, or pancreoprivic diabetes.~* Subjects with pregnancy.~* Subjects with metal implant, tattoos, or claustrophobia. MRI must be feasible.~* Subjects with severe chronic diseases, e.g. malignancies, heart or renal diseases (\> stage 3).~* Subjects not able to provide informed consent.~* Enrolled in another study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Tamil natives with Diabetes Type 2 (Type: None): Thirty Tamil natives (15 men, 15 women), representing general Tamil diabetic cohort.
- Swiss natives with Diabetes Type 2_matched (Type: None): Thirty Swiss natives (15 men, 15 women) matching the Tamil cohort.
- Swiss natives with Diabetes Type 2_not matched (Type: None): Thirty Swiss natives (15 men, 15 women), who are not matched to the Tamil cohort, representing general Swiss diabetic cohort.

Based on this trial design, predict the completion outcome and termination type (if applicable).